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breast cancer model, which was reversed
by NVP-BEZ235, a dual PI3K-mTOR
inhibitor, treatment (Eichhorn et al., 2008)
(Figure 1B, middle). Given the frequency
of mutations in this pathway, PI3K
appears to be an excellent target for
therapy. The oncology field eagerly awaits
further information on the clinical useful-
ness of PI3K inhibitors.
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Macrophage infiltration and inflammatory cytokines are powerful drivers of tumorigenesis and metastasis.
Wu et al., in this issue of Cancer Cell, show that TNFa-dependent NFkB activation induces COP9 signalo-
some-mediated inhibition of GSK3b and the SCFb-TRCP ubiquitin ligase, thus leading to stabilization of the
transcription factor Snail and promoting cell migration and metastasis.Transcription factors are prime targets for
regulation by ubiquitin-dependent pro-
teolysis. One of the best studied exam-
ples is b-catenin, a coactivator of the
TCF-LEF family of DNA-binding proteins.
In the absence of Wnt signaling, b-catenin
is constitutively phosphorylated by gly-
cogen synthase kinase 3b (GSK3b) on
two serine residues. This phosphorylation
also requires the scaffold protein axin and
the adaptor protein adenomatous polypo-
sis coli (APC), which appear to facilitate
the recruitment of b-catenin to GSK3b.
b-catenin phosphorylation triggers its
recognition by the b-TRCP substrate
receptor of a SKP1-CUL1-F-box protein
(SCF) ubiquitin ligase, thus resulting in
ubiquitylation and proteasomal degrada-
tion. Canonical Wnt signaling reverses
b-catenin destruction by preventing its
GSK3b-dependent phosphorylation.
In many colon cancers, this reversal is
mimicked by mutations in APC, thus
leading to increased b-catenin-TCFactivity and growth promoting gene ex-
pression. Within the inflammatory tumor
microenvironment, this effect can be
potentiated by two additional stimuli that
are provided by tumor-associatedmacro-
phages (TAMs). The first comes in the
form of Wnt ligands, and the second is
the proinflammatory cytokine TNFa.
Even in the absence of APC mutations,
TAM-derived TNFa can promote the
nuclear accumulation of b-catenin and
gastrointestinal tumorigenesis (Oguma
et al., 2008). The cytokine does so not
by activating its prominent target NF-kB,
but by driving Akt1-mediated, inhibitory
phosphorylation of GSK3b, which pre-
vents b-catenin from being targeted to
SCFb-TRCP.
The new study by Wu et al. (2009)
enacts a remarkably similar plot with
partly the same cast. Once again, a tran-
scription factor, Snail, escapes ubiquity-
lation by SCFb-TRCP and proteasomal
degradation. Once again, this involvesCancer CTAMs and their secreted TNFa. And
once again, this potentiates the tumor
phenotype, this time promoting metas-
tasis. However, the newly discovered
pathway has also distinctly novel aspects
and brings fresh players to the stage.
Snail is a transcription factor that
represses the expression of E-cadherin
and thereby confers onto epithelial cells
a fibroblast-like behavior that includes
increased motility. This process, known
as epithelial-mesenchymal transition
(EMT), occurs at the invasive front of
tumors, the same site where tumor infiltra-
tion by TAMs takes place. Wu et al. now
link these events by demonstrating that
TAM-derived TNFa leads to the stabiliza-
tion of Snail, which is otherwise a highly
unstable protein targeted for degradation
by GSK3b-dependent phosphorylation
and SCFb-TRCP-mediated ubiquitylation
(Zhou et al., 2004). As with b-catenin,
TNFa-mediated Snail stabilization occurs
through inhibition of GSK3b-dependentell 15, May 5, 2009 ª2009 Elsevier Inc. 355
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TNFa secreted by tumor-associated macrophages sets in motion two distinct pathways that culminate in
the stabilization and nuclear accumulation of Snail and b-catenin, thus effectively shortcircuiting the Wnt
pathway in the absence of cognate ligand. Through activation of Akt1, TNFa causes the inhibitory
phosphorylation of GSK3b, which in turn prevents the phosphorylation of b-catenin and recognition by
SCFb-TRCP (Oguma et al., 2008). TNFa also stimulates NF-kB signaling, transcription of CSN2, de novo
formation of CSN complex, and Snail stabilization by inhibition of GSK3b-mediated phosphorylation
(Wu et al., 2009). The latter process is speculated to involve sequestration of Snail from GSK3b by binding
to the CSN. Additional mechanisms might include deubiquitylation of Snail by CSN-associated USP15 or
inhibition of SCFb-TRCP by CUL1 deneddylation.phosphorylation. In diametrical opposi-
tion to b-catenin, however, Snail stabiliza-
tion is not due to inhibitory phosphoryla-
tion of GSK3b by Akt1, but instead
involves NF-kB signaling and transcrip-
tional activity.
At this juncture, the critical question
arose as to what are the transcriptional
targets of NF-kB that trigger Snail stabili-
zation. It is in answering this question
that the Wu et al. study breaks the most356 Cancer Cell 15, May 5, 2009 ª2009 Elsenew ground. They found that among 50
genes rapidly induced by TNFa, only
one can bring about Snail stabilization,
CSN2. Overexpression of CSN2 is suffi-
cient to stabilize Snail, whereas knock-
down of CSN2 prevents TNFa-induced
Snail accumulation.
CSN2 is a component of the eight
subunit COP9 signalosome (CSN) com-
plex, which is a major regulator of the
family of cullin-RING ubiquitin ligasesvier Inc.(CRLs) to which SCFb-TRCP belongs (Wolf
et al., 2003). CSN is widely viewed as an
activator of CRLs because it protects its
associated substrate receptors from
autocatalytic degradation (Wee et al.,
2005). CSN exerts this stabilizing effect
by removing the ubiquitin-like modifier
NEDD8 from cullins in a reaction that is
catalyzed by CSN subunit 5 (Cope et al.,
2002). Deneddylated CRLs are enzymati-
cally inactive and, therefore, prevented
from self-digestion. At the same time,
removal of NEDD8 allows cullins to bind
CAND1, another regulator of CRLs that
promotes the exchange of substrate
receptors.
Since only one of the eight subunits of
the CSN was induced by TNFa, it re-
mained initially unclear whether Snail
stabilization involved the entire CSN
complex. In favor of this possibility is
the demonstration that overexpression
of CSN5 also caused Snail stabilization.
In addition, it is well-established that over-
expression of CSN2 is sufficient to drive
the de novo assembly of CSN complexes
(Schweitzer et al., 2007). Yet, if CSN is an
activator of CRLs, why would an in-
creased level of CSN complex prevent
SCFb-TRCP-dependent Snail ubiquitylation
and degradation?
Although this question is not fully
answered, Wu et al. provide some tanta-
lizing clues that suggest a function of
CSN that is altogether different from its
control of CRLs by deneddylation. Impor-
tantly, they find that Snail stabilized by
TNFa or CSN2 accumulates in the un-
phosphorylated state, whereas the pro-
tein is phosphorylated when it accumu-
lates due to inhibition of the proteasome
by MG132. This finding strongly suggests
that the inhibition of Snail degradation by
TNFa occurs upstream of SCFb-TRCP,
most likely at the level of GSK3b. Indeed,
both TNFa and CSN2, but not MG132,
prevent the recruitment of Snail to
GSK3b. Thus, the main role of CSN may
be to keep Snail apart from GSK3b. This
could be achieved, for example, by tran-
siently sequestering Snail into a complex
with the CSN, thus precluding it from
GSK3b or even promoting its dephos-
phorylation (Figure 1).
Precedence for such a scenario was
previously provided by the study of
another substrate of the GSK3b-
SCFb-TRCP axis, IkBa (Schweitzer et al.,
2007). There, CSN facilitates the
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tion, apparently through recruiting the
protein to the CSN-associated deubiqui-
tylating enzyme USP15. Whether this
mechanism is also at play in CSN-medi-
ated Snail stabilization remains to be
investigated (Figure 1). Likewise, future
work will be required to clarify the role, if
any, of CSN-mediated cullin deneddyla-
tion in Snail stabilization. For example,
one wonders whether the Snail stabilizing
activity of CSN5 depends on the integrity
of its JAMM metalloprotease domain.
The finding that CAND1 is required for
CSN2-induced Snail accumulation is
intriguing in this regard, but difficult to
reconcile with other reports demon-
strating that, in vivo, CAND1 behaves as
an activator of CRLs (Zheng et al., 2002),
although this has not been established
forSCFb-TRCP. Basedon thedata availableYB-1 Translationa
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Transitions between epithelial and
cancer progression. In this issue o
thelial-mesenchyme transition (EM
promoting factors and suppressin
factors.
Metastasis is a multistep process that
mediates the spread of cancer cells from
primary tumors to distant sites. This
process relies on structural and pheno-
typic changes that enable tumor cells to
dissociate from the tumor mass, invade
the surrounding tissue, intravasate into
vascular or lymphatic vessels, and extrav-
asate and proliferate at a secondary site.
An increasing number of reports provide
evidence that epithelial cancer cells adopt
embryonic transcription programs during
the invasive phase of metastasis, which
allow them to suspend some or all of theirto date, it appears that preventing Snail
phosphorylation is the primary role of the
CSN in Snail stabilization.
Regardless of the exact mechanism,
the current study deepens the link
between inflammation and metastasis
and introduces theCSNas a further player
in these processes. The new findings
also provide initial mechanistic insight
into the emerging connection between
CSN activation and tumorigenesis (Adler
et al., 2008).
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This epithelial-to-mesenchymal transition
(EMT) is associated with changes in cell-
cell adhesion, remodeling of cell-matrix
adhesion, and enhanced migratory ac-
tivity. Several transcription factors have
been implicated in this transition, including
Snail, Slug, Zeb1, andTwist. The canonical
Ras pathway has also been shown to play
a crucial role in EMT in certain contexts.
Ras activity, however, is not sufficient to
induce EMT; other factors collaborate
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are able to invade by adopting modes of
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as collective or amoeboid (Friedl et al.,
2004). Nevertheless, an increasing body
of evidence demonstrates the occurrence
of EMT in tumor cell subpopulationsduring
the progression of certain types of cancers
(Yilmaz and Christofori, 2009; Polyak and
Weinberg, 2009), and a recent study
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